The Higher Incidence of Liver Injury in HCC Patients Compared to Other Malignancies During Immune-Checkpoint Inhibitor Therapy is Primarily Due to Tumor Progression

The Higher Incidence of Liver Injury in HCC Patients Compared to Other Malignancies During Immune-Checkpoint Inhibitor Therapy is Primarily Due to Tumor Progression

Yan Wang,1,* Liwei Liu,2,* Mengyu Zhao,1,* Wei Chen,3 Yu Chen,2 Xinyan Zhao1 1Liver Research Center, Beijing Friendship Hospital, Key Laboratory on Translational Medicine on Cirrhosis, National Clinical Research Center for Digestive Disease, Capital Medical Univer...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang Y, Liu L, Zhao M, Chen W, Chen Y, Zhao X
Format: Article
Language:English
Published: Dove Medical Press 2025-06-01
Series:Therapeutics and Clinical Risk Management
Subjects:
immune checkpoint inhibitors
hepatocarcinoma
liver injury
Online Access:https://www.dovepress.com/the-higher-incidence-of-liver-injury-in-hcc-patients-compared-to-other-peer-reviewed-fulltext-article-TCRM
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/the-higher-incidence-of-liver-injury-in-hcc-patients-compared-to-other-peer-reviewed-fulltext-article-TCRM

Similar Items